A randomized multi-center phase 2 study of combined PD-L1/CTLA-4 inhibition with or without radiation in non-small cell lung cancer patients who progressed on PD-(L)1 directed therapy: ETCTN 10021Arta Monjazeb,Anita Giobbie-Hurder,Ana Lako,Mark Awad,Ryan Gentzler,Carrie Lee,Joleen Hubbard,James Abbruzzese,Salma Jabbour,Nataliya Uboha,Kevin Stephans,Jennifer Johnson,Haeseong Park,Liza Villaruz,Katrina Kao,Elad Sharon,David Raben,Raymond Mak,Howard Streicher,Helen Chen,Mansoor Ahmed,Scott Rodig,F. Stephen Hodi,Jonathan SchoenfeldJOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）引用 0|浏览43暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
